vs
Equity Residential（EQR）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是Equity Residential的1.8倍（$1.4B vs $781.9M），Equity Residential净利率更高（48.9% vs 27.6%，领先21.3%），瑞思迈同比增速更快（11.0% vs 2.0%），过去两年瑞思迈的营收复合增速更高（7.9% vs 3.4%）
Equity Residential是总部位于美国的公开上市房地产投资信托基金（REIT），核心业务聚焦公寓类不动产投资，在全美多地持有大量优质公寓资产，深耕租赁住房市场，拥有成熟的运营管理经验和突出的行业竞争优势。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
EQR vs RMD — 直观对比
营收规模更大
RMD
是对方的1.8倍
$781.9M
营收增速更快
RMD
高出9.0%
2.0%
净利率更高
EQR
高出21.3%
27.6%
两年增速更快
RMD
近两年复合增速
3.4%
损益表 — Q4 FY2025 vs Q4 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $781.9M | $1.4B |
| 净利润 | $382.1M | $392.6M |
| 毛利率 | — | 61.8% |
| 营业利润率 | 50.6% | 34.6% |
| 净利率 | 48.9% | 27.6% |
| 营收同比 | 2.0% | 11.0% |
| 净利润同比 | -8.8% | 13.9% |
| 每股收益（稀释后） | $1.01 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EQRRMD
| Q2 26 | — | $1.4B | ||
| Q4 25 | $781.9M | $1.4B | ||
| Q3 25 | $782.4M | $1.3B | ||
| Q2 25 | $768.8M | $1.3B | ||
| Q1 25 | $760.8M | $1.3B | ||
| Q4 24 | $766.8M | $1.3B | ||
| Q3 24 | $748.3M | $1.2B | ||
| Q2 24 | $734.2M | $1.2B |
净利润EQRRMD
| Q2 26 | — | $392.6M | ||
| Q4 25 | $382.1M | $392.6M | ||
| Q3 25 | $289.1M | $348.5M | ||
| Q2 25 | $192.4M | $379.7M | ||
| Q1 25 | $256.6M | $365.0M | ||
| Q4 24 | $419.1M | $344.6M | ||
| Q3 24 | $143.4M | $311.4M | ||
| Q2 24 | $177.5M | $292.2M |
毛利率EQRRMD
| Q2 26 | — | 61.8% | ||
| Q4 25 | — | 61.8% | ||
| Q3 25 | — | 61.5% | ||
| Q2 25 | — | 60.8% | ||
| Q1 25 | — | 59.3% | ||
| Q4 24 | — | 58.6% | ||
| Q3 24 | — | 58.6% | ||
| Q2 24 | — | 58.5% |
营业利润率EQRRMD
| Q2 26 | — | 34.6% | ||
| Q4 25 | 50.6% | 34.6% | ||
| Q3 25 | 38.5% | 33.4% | ||
| Q2 25 | 26.6% | 33.7% | ||
| Q1 25 | 35.7% | 33.0% | ||
| Q4 24 | 57.2% | 32.5% | ||
| Q3 24 | 20.1% | 31.6% | ||
| Q2 24 | 25.3% | 31.2% |
净利率EQRRMD
| Q2 26 | — | 27.6% | ||
| Q4 25 | 48.9% | 27.6% | ||
| Q3 25 | 36.9% | 26.1% | ||
| Q2 25 | 25.0% | 28.2% | ||
| Q1 25 | 33.7% | 28.3% | ||
| Q4 24 | 54.7% | 26.9% | ||
| Q3 24 | 19.2% | 25.4% | ||
| Q2 24 | 24.2% | 23.9% |
每股收益（稀释后）EQRRMD
| Q2 26 | — | $2.68 | ||
| Q4 25 | $1.01 | $2.68 | ||
| Q3 25 | $0.76 | $2.37 | ||
| Q2 25 | $0.50 | $2.58 | ||
| Q1 25 | $0.67 | $2.48 | ||
| Q4 24 | $1.10 | $2.34 | ||
| Q3 24 | $0.38 | $2.11 | ||
| Q2 24 | $0.47 | $1.97 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $55.9M | $1.4B |
| 总债务越低越好 | $8.2B | $663.8M |
| 股东权益账面价值 | $11.0B | $6.3B |
| 总资产 | $20.7B | $8.5B |
| 负债/权益比越低杠杆越低 | 0.75× | 0.11× |
8季度趋势，按日历期对齐
现金及短期投资EQRRMD
| Q2 26 | — | $1.4B | ||
| Q4 25 | $55.9M | $1.4B | ||
| Q3 25 | $93.1M | $1.4B | ||
| Q2 25 | $31.3M | $1.2B | ||
| Q1 25 | $39.8M | $932.7M | ||
| Q4 24 | $62.3M | $521.9M | ||
| Q3 24 | $28.6M | $426.4M | ||
| Q2 24 | $38.3M | $238.4M |
总债务EQRRMD
| Q2 26 | — | $663.8M | ||
| Q4 25 | $8.2B | $403.9M | ||
| Q3 25 | — | $408.7M | ||
| Q2 25 | — | $658.4M | ||
| Q1 25 | — | $663.1M | ||
| Q4 24 | $8.2B | $662.9M | ||
| Q3 24 | — | $667.6M | ||
| Q2 24 | — | $697.3M |
股东权益EQRRMD
| Q2 26 | — | $6.3B | ||
| Q4 25 | $11.0B | $6.3B | ||
| Q3 25 | $11.1B | $6.1B | ||
| Q2 25 | $11.0B | $6.0B | ||
| Q1 25 | $11.0B | $5.5B | ||
| Q4 24 | $11.0B | $5.3B | ||
| Q3 24 | $10.9B | $5.2B | ||
| Q2 24 | $11.0B | $4.9B |
总资产EQRRMD
| Q2 26 | — | $8.5B | ||
| Q4 25 | $20.7B | $8.5B | ||
| Q3 25 | $21.1B | $8.3B | ||
| Q2 25 | $21.0B | $8.2B | ||
| Q1 25 | $20.6B | $7.6B | ||
| Q4 24 | $20.8B | $7.1B | ||
| Q3 24 | $20.9B | $7.2B | ||
| Q2 24 | $19.8B | $6.9B |
负债/权益比EQRRMD
| Q2 26 | — | 0.11× | ||
| Q4 25 | 0.75× | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | 0.74× | 0.13× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $387.0M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 1.01× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流EQRRMD
| Q2 26 | — | — | ||
| Q4 25 | $387.0M | $339.7M | ||
| Q3 25 | $476.7M | $457.3M | ||
| Q2 25 | $359.5M | $538.8M | ||
| Q1 25 | $425.5M | $578.7M | ||
| Q4 24 | $354.2M | $308.6M | ||
| Q3 24 | $401.4M | $325.5M | ||
| Q2 24 | $396.9M | $440.1M |
自由现金流EQRRMD
| Q2 26 | — | — | ||
| Q4 25 | — | $311.2M | ||
| Q3 25 | — | $414.4M | ||
| Q2 25 | — | $508.2M | ||
| Q1 25 | — | $557.9M | ||
| Q4 24 | — | $288.0M | ||
| Q3 24 | — | $307.7M | ||
| Q2 24 | — | $415.2M |
自由现金流率EQRRMD
| Q2 26 | — | — | ||
| Q4 25 | — | 21.9% | ||
| Q3 25 | — | 31.0% | ||
| Q2 25 | — | 37.7% | ||
| Q1 25 | — | 43.2% | ||
| Q4 24 | — | 22.5% | ||
| Q3 24 | — | 25.1% | ||
| Q2 24 | — | 33.9% |
资本支出强度EQRRMD
| Q2 26 | — | — | ||
| Q4 25 | — | 2.0% | ||
| Q3 25 | — | 3.2% | ||
| Q2 25 | — | 2.3% | ||
| Q1 25 | — | 1.6% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 2.0% |
现金转化率EQRRMD
| Q2 26 | — | — | ||
| Q4 25 | 1.01× | 0.87× | ||
| Q3 25 | 1.65× | 1.31× | ||
| Q2 25 | 1.87× | 1.42× | ||
| Q1 25 | 1.66× | 1.59× | ||
| Q4 24 | 0.85× | 0.90× | ||
| Q3 24 | 2.80× | 1.05× | ||
| Q2 24 | 2.24× | 1.51× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
